enterovirus infectious disease
enterovirus infectious disease
Explore linked clinical trials. Standard reference: MONDO:000574738 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Risk Factors and Outcomes of Hepatitis A in Children | Digestive System Diseases, Hepatic Insufficiency, Infections, Picornaviridae infectious disease, RNA Virus Infections, acute liver failure, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, liver failure, viral hepatitis, viral infectious disease | Not yet recruiting | Not stated | 2026-09-30 | NCT07848321 | |
| Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 1 | 2026-09-29 | NCT07688369 | |
| CHIPCAT and HFMD-PREP for HFMD Prevention in Childcare Centres in Kota Kinabalu | Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, viral infectious disease | Not yet recruiting | Not applicable | 2026-09-24 | NCT07839442 | |
| Effects of Virtual Walking on Chronic Pain and Psychological Distress for Individuals With Severe Mobility Impairment | Chronic Pain, Infections, Neuroinflammatory Diseases, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, RNA Virus Infections, Signs and Symptoms, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, injury, myelitis, nervous system disorder, nervous system injury, neuromuscular disease, poliomyelitis, spinal cord disorder, spinal cord injury, viral infectious disease | Active, not recruiting | Not applicable | 2026-09-15 | NCT07820618 | |
| A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 3 | 2026-09-09 | NCT07010822 | |
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 / Phase 3 | 2026-09-03 | NCT06947499 | |
| Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children | Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, viral infectious disease | Not yet recruiting | Not applicable | 2026-09-01 | NCT07793175 | |
| Study of BK1803 in Healthy Infants | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 3 | 2026-08-28 | NCT07793513 | |
| A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-06 | NCT06577298 | |
| Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). | Echovirus infectious disease, Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, herpangina, viral infectious disease | Not yet recruiting | Phase 3 | 2026-05-28 | NCT07611513 | |
| Long-term Immunogenicity of L-HAV Vaccine Among Healthy Thai Children and Adolescents | Digestive System Diseases, Infections, Picornaviridae infectious disease, RNA Virus Infections, Vaccine-Preventable Diseases, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Not stated | 2026-05-22 | NCT07032610 | |
| Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV | Digestive System Diseases, Infections, Picornaviridae infectious disease, RNA Virus Infections, Vaccine-Preventable Diseases, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 3 | 2026-05-22 | NCT06978621 | |
| Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 2 | 2026-05-11 | NCT05654467 | |
| Nomad P-KAFO Study | CNS demyelinating autoimmune disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infections, Muscular Disorders, Atrophic, Neuroinflammatory Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, RNA Virus Infections, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, cerebrovascular disorder, demyelinating disease, enterovirus infectious disease, hereditary disease, immune system disorder, injury, multiple sclerosis, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myelitis, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, palsy, poliomyelitis, postpoliomyelitis syndrome, spinal cord disorder, spinal cord injury, stroke disorder, vascular disorder, viral infectious disease | Recruiting | Not applicable | 2026-05-11 | NCT05644522 | |
| Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses | DNA Virus Infections, Infections, Picornaviridae infectious disease, RNA Virus Infections, adenoviridae infectious disease, enterovirus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Active, not recruiting | Not applicable | 2026-04-17 | NCT05864118 | |
| Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis | Digestive System Diseases, Infections, Picornaviridae infectious disease, RNA Virus Infections, enterovirus infectious disease, hepatitis, hepatitis A virus infection, hepatitis E virus infection, liver disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Not applicable | 2026-04-13 | NCT07525401 | |
| Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11 | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, RNA Virus Infections, Sepsis, Systemic Inflammatory Response Syndrome, enterovirus infectious disease, viral infectious disease | Recruiting | Not stated | 2026-03-27 | NCT07356583 | |
| Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Charcot-Marie-Tooth disease, Chronic Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Infections, Lambert-Eaton myasthenic syndrome, Lysosomal Storage Diseases, Nervous System, Muscular Disorders, Atrophic, Neoplasms by Site, Neuroinflammatory Diseases, Nutritional and Metabolic Diseases, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, RNA Virus Infections, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, autonomic nervous system disorder, brain disorder, central nervous system disorder, central nervous system infectious disorder, central nervous system malformation, centronuclear myopathy, chronic inflammatory demyelinating polyradiculoneuropathy, congenital structural myopathy, demyelinating disease, disorder of glycogen metabolism, enterovirus infectious disease, facioscapulohumeral muscular dystrophy, glycogen storage disease II, hereditary disease, hereditary motor and sensory neuropathy, hereditary spastic paraplegia, immune system disorder, inborn carbohydrate metabolic disorder, inborn errors of metabolism, inborn mitochondrial metabolism disorder, inborn mitochondrial myopathy, inclusion body myositis, inherited neurodegenerative disorder, lateral sclerosis, lysosomal storage disease, metabolic disease, motor neuron disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myasthenia gravis, myelitis, myositis disease, nemaline myopathy, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, orthostatic intolerance, paraneoplastic syndrome, peripheral nervous system disorder, poliomyelitis, polyneuropathy, polyradiculoneuropathy, postpoliomyelitis syndrome, primary dysautonomia, progressive muscular atrophy, proteostasis deficiencies, spinal cord disorder, spinal muscular atrophy, viral infectious disease | Recruiting | Not applicable | 2026-03-17 | NCT07478172 | |
| Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 4 | 2026-03-09 | NCT07457060 | |
| Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective | Adenophorea Infections, Alphavirus infectious disease, Arenaviridae infectious disease, Bacterial Infections and Mycoses, Bunyaviridae infectious disease, Caliciviridae infectious disease, Clostridium infectious disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Encephalitis, Arbovirus, Encephalitis, Viral, Enoplea infectious disease, Epstein-Barr virus infection, Euglenozoa Infections, Flaviviridae infectious disease, Flavivirus Infections, Genital Diseases, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Infections, Arenavirus, Japanese encephalitis, Mononegavirales infectious disease, Mosquito-Borne Diseases, Mycoplasma Infections, Mycoplasmatales Infections, Neglected Diseases, Nematoda infectious disease, Neuroinflammatory Diseases, Nipah Virus Infection, Norovirus Infections, Paramyxoviridae infectious disease, Parvoviridae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, Q fever, RNA Virus Infections, Reoviridae infectious disease, Rift valley fever, Rotavirus infection, Rubivirus Infections, Secernentea Infections, Severe Fever with Thrombocytopenia Syndrome, Skin and Connective Tissue Diseases, Spirurida Infections, Stomatognathic Diseases, Togaviridae infectious disease, Trematode Infections, Tumor Virus Infections, Urogenital Diseases, Vaccine-Preventable Diseases, Varicella Zoster Virus Infection, Zika virus infectious disease, Zoonoses, adenoviridae infectious disease, arbovirus infection, bacterial infectious disease, bacterial sexually transmitted disease, bordetellosis, brain disorder, brucellosis, burkholderia infectious disease, central nervous system disorder, central nervous system infectious disorder, chickenpox, chikungunya, chlamydia infectious disease, chlamydiaceae infections, dengue disease, digestive system disorder, encephalitis, enterovirus infectious disease, filarial elephantiasis, filariasis, giardiasis, gram-negative bacterial infections, gram-positive bacterial infections, hantavirus infectious disease, helminthiasis, henipavirus infectious disease, hepatitis, hepatitis A virus infection, hepatitis E virus infection, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, infectious encephalitis, intestinal disorder, leishmaniasis, leptospirosis, liver disorder, lymphatic system disorder, lymphedema, malaria, measles, melioidosis, meningitis, morbillivirus infectious disease, mouth disorder, mumps infectious disease, nervous system disorder, non-human animal disease, parasitic infectious disease, parasitic intestinal disorder, parasitic skin disorder, parotid disorder, parotitis, pertussis, protozoa infectious disease, respiratory system disorder, respiratory tract infectious disorder, rubella, salivary gland disorder, schistosomiasis, sexually transmitted disease, skin disorder, skin disorder caused by infection, spirochaetales infections, tetanus, tick-borne encephalitis, tick-borne infectious disease, trichuriasis, vector-borne disease, viral hemorrhagic fever, viral hepatitis, viral infection of central nervous system, viral infectious disease, yellow fever | Recruiting | Not stated | 2026-01-22 | NCT07358910 | |
| Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 4 | 2026-01-21 | NCT07354269 | |
| the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines | Digestive System Diseases, Infections, Mononegavirales infectious disease, Neuroinflammatory Diseases, Paramyxoviridae infectious disease, Picornaviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, myelitis, nervous system disorder, neuromuscular disease, parotid disorder, parotitis, poliomyelitis, rubella, salivary gland disorder, spinal cord disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Not stated | 2026-01-14 | NCT07338851 | |
| Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 2 | 2026-01-09 | NCT06895486 | |
| Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine | Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, viral infectious disease | Not yet recruiting | Phase 1 | 2026-01-08 | NCT07326878 | |
| Study on the Persistence of Immunity Following EV71 Vaccination | Infections, Picornaviridae infectious disease, RNA Virus Infections, coxsackievirus infectious disease, enterovirus infectious disease, hand, foot and mouth disease, viral infectious disease | Enrolling by invitation | Not stated | 2025-08-27 | NCT07144202 |